Non-alcoholic Fatty Liver Disease (NAFLD) and Significant Hepatic Fibrosis Defined by Non-invasive Assessment in Patients with Type 2 Diabetes |
Sobhonslidsuk, Abhasnee
(Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University)
Pulsombat, Akharawit (Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University) Kaewdoung, Piyaporn (Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University) Petraksa, Supanna (Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University) |
1 | Adiels M, Taskinen MR, Boren J (2008). Fatty liver, insulin resistance, and dyslipidemia. Curr Diabetes Rep, 8, 60-4. DOI |
2 | Alberti KGM, Zimmet P, Shaw J (2005). The metabolic syndrome: a new worldwide definition. Lancet, 366, 1059-62. DOI |
3 | Angulo P, Hui JM, Marchesini E, et al (2007). The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45, 846-54. DOI |
4 | Bravo AA, Sheth SG, Chopra S (2001). Liver biopsy. N Engl J Med, 344, 495-500. DOI |
5 | Casey SP, Kemp WW, Mclean CA, et al (2012). A prospective evaluation of the role of transient elastography for the detection of hepatitis fibrosis in type 2 diabetes without liver disease. Scand J Gastroenterol, 47, 836-41. DOI |
6 | Chiou WK, Huang BY, Chou WY, et al (2011). Incidences of cancers in diabetic and non-diabetic hospitalized adult patients in Taiwan. Asian Pac J Cancer Prev, 12, 1577-81. |
7 | Cusi K (2009). Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes, 16, 141-9. DOI |
8 | Fujino Y (2007). Anthropometry, development history and mortality in the Japan collaborative cohort study for evaluation of cancer (JACC). Asian Pac J Cancer Prev, 8, 105-12. |
9 | Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. DOI ScienceOn |
10 | Hamer OW, Aguirre DA, Casola G, et al (2006). Fatty liver: Imaging patterns and pitfalls. Radiographics, 26, 1637-53. DOI |
11 | Harris MI, Flegal KM, Cowie CC, et al (1998). Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care, 21, 518-24. DOI |
12 | Hernaez R, Lazo M, Bonekamp S, et al (2011). Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology, 54, 1082-90. |
13 | Jacqueminet S, Lebray P, Morra R, et al (2008). Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol, 6, 828-31. DOI |
14 | Jung KS, Kim SU (2012). Clinical applications of transient elastography. Clin Mol Hepatol, 18, 163-73. DOI |
15 | Leite NC, Salles GF, Araujo ALE, et al (2009). Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type2 diabetes mellitus. Liver Int, 29, 113-9. DOI ScienceOn |
16 | Teli MR, James OF, Burt AD, et al (1995). The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology, 22, 1714-9. DOI |
17 | Poortahmasebi V, Alavian SM, Keyvani H, et al (2014). Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer Prev, 15, 3879-84. DOI |
18 | Schwenzer NF, Springer F, Schraml C, et al (2009). Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol, 51, 433-55. DOI |
19 | Somboon K, Siramolpiwat S, Vilaichone RK (2014). Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand. Asian Pac J Cancer Prev, 15, 3567-70. DOI ScienceOn |
20 | Tolman KG, Foneca V, Dalpiaz A, et al (2007). Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care, 30, 734-43. DOI |
21 | Trombetta M, Spiazzi G, Zoppini G, et al (2005). Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Alimen Pharmacol Ther, 22, 24-7. DOI |
22 | WHO (2000). World health organisation/international association for the study of obesity/international obesity taskforce. the asia-pacific perspective: redefining obesity and its treatment. http://www.idf.org.au/obesityreport.htm. |
23 | Wong VWS, Vergniol J, Wong GLH, et al (2010). Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology, 51, 454-62. DOI |
24 | Younossi ZM, Gramlich T, Matteoni CA, et al (2004). Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol, 2, 262-5. DOI |